"We are an Outpatient Surgical Center that focuses on providing excellent patient care for all your cardiac and vascular needs!"

During the past decade, Michigan Outpatient Vascular Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Outpatient Vascular Institute" #1 sponsor was "Horizons International Peripheral Group" with 2 trials, followed by "Cardiovascular Systems Inc" with 1 trials sponsored, "Rex Medical" with 1 trials sponsored, "Veryan Medical Ltd." with 1 trials sponsored and "Vesper Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Outpatient Vascular Institute" #1 collaborator was "Advanced Catheter Therapies, Inc." with 2 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "Syntactx" with 1 trials as a collaborator and "Yale Cardiovascular Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Outpatient Vascular Institute" are "Peripheral Arterial Disease" (3 trials), "Peripheral Vascular Disease" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Michigan Outpatient Vascular Institute" in a lesser frequency.

Most popular intervention types in "Michigan Outpatient Vascular Institute" are "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel administration using the OPC" (2 trials), "BioMimics 3D Vascular Stent System" (1 trials), "Duo Venous Stent System" (1 trials), "PAD endovascular treatments" (1 trials) and "Revolution™ Peripheral Atherectomy System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Outpatient Vascular Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Outpatient Vascular Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Michigan Outpatient Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Outpatient Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".